Company Description

Swedish Biomimetics 3000 is focused on commercialising an innovative, biomimetically inspired, pharmaceutical manufacturing technology.

Swedish Biomimetics 3000 was founded by Lars-Uno Larsson, founder of Swedish Orphan International AB. Swedish Biomimetics 3000 is focused on commercialising innovative, biomimetically inspired platform technologies. The technology which is the current focus of development is µLOT.